At its J.P. Morgan Conference 2026 presentation, Qiagen NV alluded to positive full-year results for 2025 and expressed that ...

Within the category of In Vitro Diagnostic (IVD) devices, IVD consumables are projected to experience the highest compound ...

The EU’s IVDR provides a regulatory basis for establishing the safety and effectiveness of new in-vitro diagnostic (IVD) ...

AXIM Biotechnologies, Inc. ("AXIM" or the "Company") (OTC:AXIM), a diagnostic and biotechnology company advancing clinically validated solutions for ocular and inflammatory diseases, today announced ...

The microfluidics market offers opportunities in diagnostic healthcare, driven by the demand for precise, rapid PoCT ...

The "A Regulatory Update on the Medical Device and In-Vitro Diagnostic Regulations in the EU (European Union) and UK Training Course (Apr 29, 2026)" training has been added to ResearchAndMarkets.com's ...

The EU's IVDR provides a regulatory basis for establishing the safety and effectiveness of new in-vitro diagnostic (IVD) ...

CobbleStone Software, a leader in contract lifecycle management (CLM) solutions, is inviting legal, procurement, and contract ...

Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast and accurate detection of 11 clinically relevant gastrointestinal (GI) ...

The company may look to raise about ₹300-400 crore, and the promoters may liquidate some stake for the incoming investor.

DNV is a trusted Notified Body for medical device certification under the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR). We provide independent, rigorous, and ...

Augurex CEO Neil Klompas discusses goals for the company in this clip from the latest episode of Let’s Talk Medtech.